Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
D 7.67 -2.91% -0.23
AYTU closed down 2.91 percent on Friday, February 26, 2021, on 53 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical AYTU trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -2.91%
20 DMA Resistance Bearish -4.60%
Narrow Range Bar Range Contraction -4.60%
NR7 Range Contraction -4.60%
Fell Below 20 DMA Bearish -2.79%
Hammer Candlestick Bullish -2.79%
Crossed Above 20 DMA Bullish -8.36%
20 DMA Resistance Bearish -4.96%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.96%
Narrow Range Bar Range Contraction -4.96%
Older End-of-Day Signals for AYTU ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 3% 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aytu BioScience, Inc. Description

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Prostate Cancer Urology In Vitro Alcohols Hormones Fertility Ketones Testosterone Imaging Agent Infertility Urinary Tract Infection Urinary Tract Infections Company's Pipeline In Vitro Diagnostic Device Male Infertility Androstanes Hypogonadism

Is AYTU a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.9
52 Week Low 3.352
Average Volume 667,371
200-Day Moving Average 11.06
50-Day Moving Average 7.37
20-Day Moving Average 8.12
10-Day Moving Average 8.13
Average True Range 0.56
ADX 24.27
+DI 21.39
-DI 22.08
Chandelier Exit (Long, 3 ATRs ) 7.66
Chandelier Exit (Short, 3 ATRs ) 8.52
Upper Bollinger Band 9.11
Lower Bollinger Band 7.14
Percent B (%b) 0.27
BandWidth 24.23
MACD Line 0.08
MACD Signal Line 0.19
MACD Histogram -0.1082
Fundamentals Value
Market Cap 981.22 Million
Num Shares 128 Million
EPS -3.48
Price-to-Earnings (P/E) Ratio -2.20
Price-to-Sales 1.66
Price-to-Book 1.29
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.23
Resistance 3 (R3) 8.26 8.10 8.14
Resistance 2 (R2) 8.10 7.96 8.09 8.11
Resistance 1 (R1) 7.89 7.87 7.81 7.86 8.08
Pivot Point 7.73 7.73 7.69 7.71 7.73
Support 1 (S1) 7.51 7.59 7.43 7.48 7.26
Support 2 (S2) 7.35 7.50 7.34 7.23
Support 3 (S3) 7.14 7.35 7.20
Support 4 (S4) 7.11